You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

BLEPHAMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Blephamide, and what generic alternatives are available?

Blephamide is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in BLEPHAMIDE is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BLEPHAMIDE?
  • What are the global sales for BLEPHAMIDE?
  • What is Average Wholesale Price for BLEPHAMIDE?
Summary for BLEPHAMIDE
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 2
Clinical Trials: 1
Patent Applications: 96
Drug Prices: Drug price information for BLEPHAMIDE
What excipients (inactive ingredients) are in BLEPHAMIDE?BLEPHAMIDE excipients list
DailyMed Link:BLEPHAMIDE at DailyMed
Drug patent expirations by year for BLEPHAMIDE
Drug Prices for BLEPHAMIDE

See drug prices for BLEPHAMIDE

Recent Clinical Trials for BLEPHAMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts Eye and Ear InfirmaryPhase 4
Joseph B. Ciolino, MDPhase 4

See all BLEPHAMIDE clinical trials

US Patents and Regulatory Information for BLEPHAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan BLEPHAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 012813-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Allergan BLEPHAMIDE S.O.P. prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087748-001 Dec 3, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.